Biocon has inked an exclusive pact with US-based Safety Syringes Inc., to introduce ultra safe passive delivery system technology in the form of pre-filled syringes (PFS) for two life saving products, Erypro Safe with EPO (Erythropoitin) for nephrology and Nufil Safe for GCSF (granulocyte-colony stimulating factor ) for cancer patients. The novel drug delivery device is being introduced for the first time in the country. Biocon has incurred expenditure around Rs 10 crore for the research and the clinical trials.
The whole story can be read here.
No comments:
Post a Comment